Intranasal Drug Delivery Market Report

Global and Region Intranasal Drug Delivery Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：143
  • REPORT CODE：GMM978946
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Intranasal Drug Delivery market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Intranasal Drug Deliverymarket, defines the market attractiveness level of Intranasal Drug Delivery market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Intranasal Drug Delivery industry, describes the types of Intranasal Drug Delivery market, the applications of major players and the market size, and deeply analyzes the current situation of the global Intranasal Drug Delivery market and the development prospects and opportunities of Intranasal Drug Delivery industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Intranasal Drug Delivery market in Chapter 13.

    By Player:

    • GlaxoSmithKline

    • Nemera

    • AptarGroup

    • BD

    • OptiNose

    • Johnson & Johnson

    • AstraZeneca

    • Pfizer

    • 3M

    • Becton Dickinson

    • Teleflex

    • Novartis

    • Bespak

    • Merck

    By Type:

    • Multidose

    • Unidose

    • Bidose

    By End-User:

    • Personal Use

    • Hospital Use

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Intranasal Drug Delivery Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Intranasal Drug Delivery Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Intranasal Drug Delivery Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Intranasal Drug Delivery Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Intranasal Drug Delivery Market Analysis and Outlook to 2022

    • 7.1 Global Intranasal Drug Delivery Consumption (2017-2022)

    • 7.2 United States Intranasal Drug Delivery Consumption (2017-2022)

    • 7.3 Europe Intranasal Drug Delivery Consumption (2017-2022)

    • 7.4 China Intranasal Drug Delivery Consumption (2017-2022)

    • 7.5 Japan Intranasal Drug Delivery Consumption (2017-2022)

    • 7.6 India Intranasal Drug Delivery Consumption (2017-2022)

    • 7.7 South Korea Intranasal Drug Delivery Consumption (2017-2022)

    8 Region and Country-wise Intranasal Drug Delivery Market Analysis and Outlook to 2028

    • 8.1 Global Intranasal Drug Delivery Consumption Forecast (2022-2028)

    • 8.2 United States Intranasal Drug Delivery Consumption Forecast (2022-2028)

    • 8.3 Europe Intranasal Drug Delivery Consumption Forecast (2022-2028)

    • 8.4 China Intranasal Drug Delivery Consumption Forecast (2022-2028)

    • 8.5 Japan Intranasal Drug Delivery Consumption Forecast (2022-2028)

    • 8.6 India Intranasal Drug Delivery Consumption Forecast (2022-2028)

    • 8.7 South Korea Intranasal Drug Delivery Consumption Forecast (2022-2028)

    9 Global Intranasal Drug Delivery Market Outlook by Types and Applications to 2022

    • 9.1 Global Intranasal Drug Delivery Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Multidose Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Unidose Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Bidose Consumption and Growth Rate (2017-2022)

    • 9.2 Global Intranasal Drug Delivery Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Personal Use Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Use Consumption and Growth Rate (2017-2022)

    10 Global Intranasal Drug Delivery Market Outlook by Types and Applications to 2028

    • 10.1 Global Intranasal Drug Delivery Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Multidose Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Unidose Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Bidose Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Intranasal Drug Delivery Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Personal Use Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)

    11 Global Intranasal Drug Delivery Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Intranasal Drug Delivery Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Intranasal Drug Delivery Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Intranasal Drug Delivery Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Intranasal Drug Delivery Market Competitive Analysis

    • 14.1 GlaxoSmithKline

      • 14.1.1 GlaxoSmithKline Company Details

      • 14.1.2 GlaxoSmithKline Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GlaxoSmithKline Intranasal Drug Delivery Product and Service

    • 14.2 Nemera

      • 14.2.1 Nemera Company Details

      • 14.2.2 Nemera Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Nemera Intranasal Drug Delivery Product and Service

    • 14.3 AptarGroup

      • 14.3.1 AptarGroup Company Details

      • 14.3.2 AptarGroup Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 AptarGroup Intranasal Drug Delivery Product and Service

    • 14.4 BD

      • 14.4.1 BD Company Details

      • 14.4.2 BD Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 BD Intranasal Drug Delivery Product and Service

    • 14.5 OptiNose

      • 14.5.1 OptiNose Company Details

      • 14.5.2 OptiNose Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 OptiNose Intranasal Drug Delivery Product and Service

    • 14.6 Johnson & Johnson

      • 14.6.1 Johnson & Johnson Company Details

      • 14.6.2 Johnson & Johnson Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Johnson & Johnson Intranasal Drug Delivery Product and Service

    • 14.7 AstraZeneca

      • 14.7.1 AstraZeneca Company Details

      • 14.7.2 AstraZeneca Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 AstraZeneca Intranasal Drug Delivery Product and Service

    • 14.8 Pfizer

      • 14.8.1 Pfizer Company Details

      • 14.8.2 Pfizer Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Intranasal Drug Delivery Product and Service

    • 14.9 3M

      • 14.9.1 3M Company Details

      • 14.9.2 3M Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 3M Intranasal Drug Delivery Product and Service

    • 14.10 Becton Dickinson

      • 14.10.1 Becton Dickinson Company Details

      • 14.10.2 Becton Dickinson Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Becton Dickinson Intranasal Drug Delivery Product and Service

    • 14.11 Teleflex

      • 14.11.1 Teleflex Company Details

      • 14.11.2 Teleflex Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Teleflex Intranasal Drug Delivery Product and Service

    • 14.12 Novartis

      • 14.12.1 Novartis Company Details

      • 14.12.2 Novartis Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Novartis Intranasal Drug Delivery Product and Service

    • 14.13 Bespak

      • 14.13.1 Bespak Company Details

      • 14.13.2 Bespak Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Bespak Intranasal Drug Delivery Product and Service

    • 14.14 Merck

      • 14.14.1 Merck Company Details

      • 14.14.2 Merck Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Merck Intranasal Drug Delivery Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Intranasal Drug Delivery

    • Figure Intranasal Drug Delivery Picture

    • Table Global Intranasal Drug Delivery Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Intranasal Drug Delivery Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Intranasal Drug Delivery Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Intranasal Drug Delivery Consumption by Country (2017-2022)

    • Figure United States Intranasal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table Europe Intranasal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure China Intranasal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Japan Intranasal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure India Intranasal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure South Korea Intranasal Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Global Intranasal Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure United States Intranasal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Intranasal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Intranasal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Intranasal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Intranasal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Intranasal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multidose Consumption and Growth Rate (2017-2022)

    • Figure Global Unidose Consumption and Growth Rate (2017-2022)

    • Figure Global Bidose Consumption and Growth Rate (2017-2022)

    • Figure Global Personal Use Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Use Consumption and Growth Rate (2017-2022)

    • Figure Global Multidose Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Unidose Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bidose Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Personal Use Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Intranasal Drug Delivery Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Intranasal Drug Delivery Export by Region (Top 5 Countries) (2017-2028)

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Intranasal Drug Delivery Product and Service

    • Table Nemera (Foundation Year, Company Profile and etc.)

    • Table Nemera Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nemera Intranasal Drug Delivery Product and Service

    • Table AptarGroup (Foundation Year, Company Profile and etc.)

    • Table AptarGroup Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table AptarGroup Intranasal Drug Delivery Product and Service

    • Table BD (Foundation Year, Company Profile and etc.)

    • Table BD Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table BD Intranasal Drug Delivery Product and Service

    • Table OptiNose (Foundation Year, Company Profile and etc.)

    • Table OptiNose Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table OptiNose Intranasal Drug Delivery Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Intranasal Drug Delivery Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Intranasal Drug Delivery Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Intranasal Drug Delivery Product and Service

    • Table 3M (Foundation Year, Company Profile and etc.)

    • Table 3M Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3M Intranasal Drug Delivery Product and Service

    • Table Becton Dickinson (Foundation Year, Company Profile and etc.)

    • Table Becton Dickinson Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson Intranasal Drug Delivery Product and Service

    • Table Teleflex (Foundation Year, Company Profile and etc.)

    • Table Teleflex Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teleflex Intranasal Drug Delivery Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Intranasal Drug Delivery Product and Service

    • Table Bespak (Foundation Year, Company Profile and etc.)

    • Table Bespak Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bespak Intranasal Drug Delivery Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Intranasal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Intranasal Drug Delivery Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US